Iain A. M. MacPhee
St. George's
University of London
London
UK
Name/email consistency: high
- Use of pharmacogenetics to optimize immunosuppressive therapy. Macphee, I.A. Ther. Drug. Monit (2010)
- A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. MacPhee, I.A., Holt, D.W. Transplantation (2008)
- Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunity. MacPhee, I.A., Yagita, H., Oliveira, D.B. Immunology (2006)
- Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?. MacPhee, I.A., Fredericks, S., Holt, D.W. Expert. Opin. Pharmacother (2005)